Prognostic significance of Bax and Fas Ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma

被引:18
|
作者
Kokturk, N
Firat, P
Akay, H
Kadilar, C
Ozturk, C
Zorlu, F
Gungen, Y
Emri, S
机构
[1] Gazi Univ, Sch Med, Dept Pulm Med, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Thorac Surg, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Stat, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Sch Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
[6] Hacettepe Univ, Sch Med, Dept Pulm Med, TR-06100 Ankara, Turkey
关键词
mesothelioma; erionite; asbestos; apoptosis; Bax; Fas Ligand;
D O I
10.1016/j.lungcan.2005.05.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Environmentally exposed erionite is a potent and unique inducer of malignant pleural mesothelioma (MPM) in Central Anatolia in Turkey. Previous studies have shown that erionite induced MPM has different biological behavior than asbestos induced MPM. Although impaired apoptosis has been implicated in tumor biology, the relationship between the type of environmental exposure and apoptosis has not yet been evaluated in MPM. The purpose of this study was to determine the expression of apoptosis regulating proteins and their prognostic significance in erionite and asbestos induced MPM. Thirty-five patients with MPM (16 erionite and 19 asbestos induced), and 17 patients with adenocarcinoma were comparatively evaluated. Expression of Bcl-2, Bax, Fas and Fas Ligand, were assessed by immunohistochemistry. Bcl-2 and Fas did not stain in almost all specimens. The staining extension of Bax was 13.75 +/- 19.27%, 5.89 +/- 14.51% and 7.38 +/- 14.53% for erionite and asbestos induced MPM and adenocarcinoma, respectively (p = 0.566). The staining extension of Fas Ligand was 26.87 +/- 31.87%, 46.10 +/- 37.30% and 26.47 +/- 23.23% for erionite and asbestos induced MPM, and adenocarcinoma, respectively (p = 0.123). Bax negative patients in erionite group had longer survival than Bax positive patients (18 months versus 14 months) (p = 0.06). Fas Ligand positive patients showed statistically better survival than Fas Ligand negative patients in all MPM group (15 months versus 12 months) (p = 0.05). Although all proteins expressed in similar extension in all samples, Bax staining displayed an inverse relation with survival in erionite group. This may implicate a difference in Bax functioning in erionite induced MPM. However, Fas Ligand may be functionally intact to reduce tumor survival. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [1] Erionite-associated malignant pleural mesothelioma in Mexico
    Oczypok, Elizabeth A.
    Sanchez, Matthew S.
    Van Orden, Drew R.
    Berry, Gerald J.
    Pourtabib, Kristina
    Gunter, Mickey E.
    Roggli, Victor L.
    Kraynie, Alyssa M.
    Oury, Tim D.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5722 - 5732
  • [2] Clinical and Prognostic Features of Erionite-Induced Malignant Mesothelioma
    Demirer, Ersin
    Ghattas, Christian F.
    Radwan, Mohamed O.
    Elamin, Elamin M.
    YONSEI MEDICAL JOURNAL, 2015, 56 (02) : 311 - 323
  • [3] Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma
    Emri, S
    Akbulut, H
    Zorlu, F
    Dinçol, D
    Akay, H
    Güngen, Y
    Içli, F
    LUNG CANCER, 2001, 33 (2-3) : 109 - 114
  • [4] CT FINDINGS IN MALIGNANT PLEURAL MESOTHELIOMA RELATED TO NONOCCUPATIONAL EXPOSURE TO ASBESTOS AND FIBROUS ZEOLITE (ERIONITE)
    ERZEN, C
    ERYILMAZ, M
    KALYONCU, F
    BILIR, N
    SAHIN, A
    BARIS, YI
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (02) : 256 - 260
  • [5] Non-Asbestos-related Malignant Pleural Mesothelioma
    Kanbay, Asiye
    Simsek, Zuhal Ozer
    Tutar, Nuri
    Yilmaz, Insu
    Buyukoglan, Hakan
    Canoz, Ozlem
    Demir, Ramazan
    INTERNAL MEDICINE, 2014, 53 (17) : 1977 - 1979
  • [6] The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma
    Tanriverdi, Zubeyde
    Meteroglu, Fatih
    Yuce, Hande
    Senyigit, Abdurrahman
    Iscan, Mumtaz
    Unuvar, Songul
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (11) : 1817 - 1824
  • [7] ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA
    Sambasivarao, Gorantla
    Usharani, Namballa
    Babu, Tupakula Suresh
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (22): : 6026 - 6030
  • [8] Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects
    Mohr, S
    Keith, G
    Rihn, B
    BULLETIN DU CANCER, 2005, 92 (11) : 959 - 976
  • [9] PROGNOSTIC FACTORS AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
    VANGELDER, T
    DAMHUIS, RAM
    HOOGSTEDEN, HC
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (06) : 1035 - 1038
  • [10] Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
    Di Muzio, M
    Spoletini, L
    Strizzi, L
    Vianale, G
    Fontana, V
    Orengo, MA
    Tassi, G
    Casalini, A
    Mutti, L
    Procopio, A
    HUMAN PATHOLOGY, 2000, 31 (11) : 1341 - 1345